GLENMARK PHARMACEUTICALS USA

Pharmaceutical manufacturing

Filings
33
Clients
1
Total Income
—
Years Active
2017–2024

Filings

All 20242023202220212020201920182017
Year Client Period Income Expenses Doc
2019 GLENMARK PHARMACEUTICALS USA 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		— $135,000
2019 GLENMARK PHARMACEUTICALS USA 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		— $383,000
2019 GLENMARK PHARMACEUTICALS USA 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		— $135,000
2019 GLENMARK PHARMACEUTICALS USA 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		— $359,421

Clients Represented

ClientFilingsTotal Income
GLENMARK PHARMACEUTICALS USA 33 —

Lobbyists

NameDisclosed Prior Position
GRANT ERDEL Senator Christopher Bond - Legislative Correspondent Representative Jo Ann Emerson - Administration Assistant Represen…